Overview
Hala Borno is a primary care provider, practicing in Internal Medicine in Berkeley, California. Dr. Borno is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Familial Wilms Tumor 2, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Wilms Tumor, and Orchiectomy.
Her clinical research consists of co-authoring 74 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3100 San Pablo Ave, Berkeley, CA 94702
400 Parnassus Ave, San Francisco, CA 94143
2330 Post St, San Francisco, CA 94115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Won Kim is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Endoscopic Transnasal Transsphenoidal Surgery, and Thalamotomy.
San Jose Medical Center
Priya Rao is a primary care provider, practicing in Internal Medicine in San Jose, California. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Skeletal-Extraskeletal Angiomatosis, Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Nephrectomy, and Penectomy. Dr. Rao is currently accepting new patients.
Yin-yin Myint is a primary care provider, practicing in Internal Medicine in South San Francisco, California. Dr. Myint is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Type 2 Diabetes (T2D), Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Familial Wilms Tumor 2.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Borno isAdvanced. Learn about Clear Cell Sarcoma.
- COVID-19Dr. Borno isAdvanced. Learn about COVID-19.
- Familial Wilms Tumor 2Dr. Borno isAdvanced. Learn about Familial Wilms Tumor 2.
- Ogilvie SyndromeDr. Borno isAdvanced. Learn about Ogilvie Syndrome.
- Renal Cell Carcinoma (RCC)Dr. Borno isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- ChoriocarcinomaDr. Borno isExperienced. Learn about Choriocarcinoma.
- Diabetic KetoacidosisDr. Borno isExperienced. Learn about Diabetic Ketoacidosis.
- Familial Colorectal CancerDr. Borno isExperienced. Learn about Familial Colorectal Cancer.
- Intestinal Pseudo-ObstructionDr. Borno isExperienced. Learn about Intestinal Pseudo-Obstruction.
- Kienbock's DiseaseDr. Borno isExperienced. Learn about Kienbock's Disease.
- Muscle Invasive Bladder CancerDr. Borno isExperienced. Learn about Muscle Invasive Bladder Cancer.